GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Cyclically Adjusted PS Ratio

Eisai Co (Eisai Co) Cyclically Adjusted PS Ratio : 0.86 (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Eisai Co Cyclically Adjusted PS Ratio?

As of today (2024-05-22), Eisai Co's current share price is $10.53. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $12.22. Eisai Co's Cyclically Adjusted PS Ratio for today is 0.86.

The historical rank and industry rank for Eisai Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

ESAIY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.64   Med: 0.91   Max: 1.54
Current: 0.9

During the past years, Eisai Co's highest Cyclically Adjusted PS Ratio was 1.54. The lowest was 0.64. And the median was 0.91.

ESAIY's Cyclically Adjusted PS Ratio is ranked better than
73.92% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs ESAIY: 0.90

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eisai Co's adjusted revenue per share data for the three months ended in Mar. 2024 was $1.108. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $12.22 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eisai Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted PS Ratio Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.95 0.75 0.98 0.84

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.29 1.09 0.94 0.84

Competitive Comparison of Eisai Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.



Eisai Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eisai Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10.53/12.22
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.108/107.2000*107.2000
=1.108

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.556 98.000 4.984
201409 4.426 98.500 4.817
201412 4.079 97.900 4.466
201503 4.059 97.900 4.445
201506 3.930 98.400 4.281
201509 3.960 98.500 4.310
201512 4.332 98.100 4.734
201603 3.753 97.900 4.110
201606 4.543 98.100 4.964
201609 4.560 98.000 4.988
201612 4.193 98.400 4.568
201703 4.015 98.100 4.387
201706 4.465 98.500 4.859
201709 4.513 98.800 4.897
201712 4.783 99.400 5.158
201803 5.280 99.200 5.706
201806 4.859 99.200 5.251
201809 4.881 99.900 5.238
201812 4.885 99.700 5.252
201903 5.505 99.700 5.919
201906 4.971 99.800 5.340
201909 4.713 100.100 5.047
201912 5.973 100.500 6.371
202003 6.782 100.300 7.249
202006 5.368 99.900 5.760
202009 5.003 99.900 5.369
202012 6.092 99.300 6.577
202103 4.736 99.900 5.082
202106 1.575 99.500 1.697
202109 5.175 100.100 5.542
202112 1.555 100.100 1.665
202203 1.404 101.100 1.489
202206 1.199 101.800 1.263
202209 1.061 103.100 1.103
202212 1.212 104.100 1.248
202303 1.293 104.400 1.328
202306 1.215 105.200 1.238
202309 1.041 106.200 1.051
202312 1.076 106.800 1.080
202403 1.108 107.200 1.108

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eisai Co  (OTCPK:ESAIY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eisai Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (Eisai Co) Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (Eisai Co) Headlines